ARCHIVES

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Could Fund Some Challenge Grants That Miss NIH Funding, Director Says

June 26, 2009

Exercisers May Have Higher Breast Cancer Survival

October 27, 2006

New Trial For Metastatic Colorectal Cancer Testing Vaccine-Chemotherapy Combination

March 29, 2002

The Emergence Of The National Dialogue On Cancer, 2000-2002: Special Report

August 8, 2003

Alcohol Consumption Increases Risk Of Lobular And HR+ Breast Cancer

August 27, 2010

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

June 20, 2003